Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACC)
OACC Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-6.60%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
OACC Stock Analysis
OACC
PE Ratio:
35.5
OACC
PEG Ratio:
Not Available
OACC
Forward EPS Growth (12 month):
0.00%
OACC
PS Ratio:
OACC
PSG Ratio:
Not Available
OACC
Forward Revenue Growth (12 month):
0.00%
OACC Articles
No data was found